The Future and Medivitals
Medivitals was established in January 2020 with a vision to progress the development of a bio-marker monitoring and AI based clinical decision support platform with high sensitivity and specificity for early detection of diseases. Drawing on a strong background in digital health, telemedicine and health informatics, the company has moved into the early stages of development with a focus on using the latest technology to innovate the future of Virtual Healthcare.
Through its Chief Innovation Officer, Medivitals boasts considerable experience in developing and deploying medical diagnostic devices from bench to bedside with history of a patent portfolio of over 35 patents. One of these devices, EyeScan, for diagnosing anterior segment and retinal diseases, is used by NASA at the International Space Station and many eye clinics in USA and Europe.
Our CEO was the Minister for Health’s nominee on the Western Australian “Sustainable Health Review” which reviewed the next $120bn spend in State funding and recommended significant investment into Care in the Community, digital health, new patient experience and smarter use of data. This allowed Medivitals to position itself in the key role to elevate the importance of digital health in transforming health services.
The Medivitals solution will focus on significant opportunities in hospitals, emergency clinics, aged care facilities, remote and rural areas, mining sites and quarantine hotels/homes.
The Medivitals product will bring enormous economic benefits to Health services. It will enable early detection of diseases and prevent disease complications. It is an ideal technology for remote screening and monitoring, and telemedicine-based consultations. The digital health market is estimated at $500bn growing at 21% and this bio-band and data platform will revolutionise real time data gathering and telehealth.
Some of the applications of the Medivitals solution include
Acute care and active monitoring of post-surgery / recovery patients
Remote management of patients in aged care facilities, independent living units, residential care and nursing home
Remote indigenous communities
Remote mine monitoring of FIFO workers
Domestic violence and elevated anxiety levels
People living with disability who can benefit from digital health to complement formal and informal care
Defense veterans and PTSD impacts
Interstate and international visitors during pandemic quarantine
Proposed innovation will bring enormous economic benefits to Health services. It will enable early detection of diseases and prevent disease complications. It is an ideal technology for remote screening and monitoring, and telemedicine-based consultations. The digital health market is estimated at $500bn growing at 21% and this bio-band and data platform can revolutionise real time data gathering and telehealth.
Five of the important vital signs routinely monitored are:
Respiration rate (rate of breathing)
SpO2 or Oxygen saturation